Cadila Health can head up to Rs 857-860: Gujral

ALSO READ See previous views by Ashwani Gujral See what other Experts & Brokerages are saying about Cadila Health See messages about Cadila Health Cadila Health BSE | NSE 10/02/12 Are Mutual Funds betting on Cadila Health?

Cadila Healthcare can head up to Rs 857-860, says Technical Analyst, Ashwani Gujral .

Gujral told CNBC-TV18, "Cadila Healthcare has got support around Rs 815, it broke out above that. Chances are over a period of time it is likely to head towards levels of Rs 857-860 but for the day a target of Rs 830 could be easily possible."

He further added, "In case we remain in this 5150-5300 zone we have seen that midcap pharma is trying to show moves, so that is a sector people can remain in."

Cadila Health touched an intraday high of Rs 831.05 and an intraday low of Rs 809. At 11:36 hrs the share was quoting at Rs 826.00, up Rs 15.00, or 1.85% with volumes of 16,347 shares.

Market capitalisation stands at Rs 11,274.82 crore.

The company's trailing 12-month (TTM) EPS was at Rs 30.39 per share. The stock's price-to-earnings (P/E) ratio was 27.18. The latest book value of the company is Rs 90.32 per share. At current value, the price-to-book value of the company was 9.15. The dividend yield of the company was 0.54%.